Status:
COMPLETED
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Nicotine Dependence
Eligibility:
All Genders
21+ years
Phase:
PHASE2
Brief Summary
The goal of this research is to understand the potential impact of two new FDA strategies to ensure the availability of safer Alternative Nicotine Delivery Systems (ANDS) and to reduce the nicotine co...
Detailed Description
Design and Objective: The primary goal of this research is to assess the ability of alternative products (VLNCs vs. e-cigs vs. no alternative product; between-subjects factor) to serve as a substitute...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- smoking \>4 cigarettes/day for the previous 6 months
- able to read, write, and speak English
- no plans to quit smoking in the next 30 days
- not currently taking smoking cessation medication
- willing and medically able to use nicotine patches
- exhaled carbon monoxide (CO) \> 6 ppm.
- Exclusion criteria:
- currently in treatment for psychosis or bipolar disorder
- e-cigarette use within the last month
- currently pregnant or breastfeeding.
Exclusion
Key Trial Info
Start Date :
September 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2022
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT04084210
Start Date
September 9 2020
End Date
May 23 2022
Last Update
May 25 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Center for Tobacco Research and Intervention
Madison, Wisconsin, United States, 53711
2
UW Center for Tobacco Research and Intervention
Milwaukee, Wisconsin, United States, 53233